Some stimulate growth hormone
A high safety profile agrees with a Phase 1 clinical trial of GBS-01, an orally administered drug rich in arctigenin, whereby no dose-limiting toxicities were observed [82]
Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects from FDA-approved products
For example, an oft-cited study that attributed a 4-fold increase in GH levels to CJC-1295 was conducted on rats [3]
"As the demand continues to grow, there continues to be a shortage of conventionally manufactured product, and compounding pharmacies are filling that need," said Tenille Davis, the chief advocacy officer for the Alliance of Pharmacy Compounding, to Stateline in July